Accès ouvert
2024
article
OpenAlex
Nicoletta Staropoli, Francesca Scionti, Valentina Farenza, Federica Falcone et autres
BACKGROUND: Long-term survival induced by anticancer treatments discloses emerging frailty among breast cancer (BC) survivors. Trastuzumab-induced cardiotoxicity (TIC) is reported in at least 5% of HER2+BC patients. However, TIC mechanism remains unclear and predictive genetic biomarkers are still lacking. Interaction between systemic …
it
(code pays fourni par la source)
Accès ouvert
2023
review
OpenAlex
Nicoletta Staropoli, Angela Salvino, Federica Falcone, Valentina Farenza et autres
Background: The optimal strategy for the treatment of recurrent and/or advanced endometrial cancer is still undefined. Recently, despite the lack of any predictive biomarker, the combination of pembrolizumab with lenvatinib has improved survival outcomes. We here report the long-term management of lung …
it
(code pays fourni par la source)
Accès ouvert
2022
review
OpenAlex
Maria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, Alessia Cordua et autres
Among deregulated microRNAs (miRs) in human malignancies, miR-221 has been widely investigated for its oncogenic role and as a promising biomarker. Moreover, recent evidence suggests miR-221 as a fine-tuner of chronic liver injury and inflammation-related events. Available information also supports the potential …
it
(code pays fourni par la source)